Program
Lenalidomide
Also written as “lenalidomide”, “CC-5013” and “Drug: Carfilzomib + Lenalidomide + Dexamethasone”.
Its studies are mostly in Multiple Myeloma · Lymphoma, Large B-Cell, Diffuse · Myelodysplastic Syndromes · Lymphoma, Non-Hodgkin · Lymphoma, Mantle-Cell, led by 6 companies.
Drug pageLenalidomide: every studyMany companies study it; this page follows only the 78 they lead. All 751 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bristol-Myers Squibb | 670 open or running | phase 3since Mar 5, 2003 | Aug 16, 2002 | none ahead |
| Takedaits history only | 50 open or running | phase 4since May 30, 2017 | Jul 25, 2007 | none ahead |
| Oncotherapeuticsits history only | 32 open or running | phase 2since Jul 30, 2014 | Jul 30, 2014 | none ahead |
| bionor-immuno-asits history only | 10 open or running | phase 2since Sep 11, 2012 | Sep 11, 2012 | none ahead |
| Samyang Biopharmaceuticalsits history only | 10 open or running | phase 1since Jun 25, 2017 | Jun 25, 2017 | none ahead |
| starton-therapeutics-incits history only | 11 open or running | phase 2since Sep 20, 2023 | Sep 20, 2023 | May 31, 2027phase 2 · NCT06087653 |
Also a collaborator on its studies: AbbVie, Prologue Research International, Karyopharm Therapeutics, Incyte, Johnson & Johnson, Abbott, ICON Clinical Research and Hoffmann-La Roche.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Bristol-Myers Squibb only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 46 studies since Jul 17, 2003.
- May 4, 2012Phase 2 study in Multiple MyelomaNCT01593410 · 194 enrolled · China
- Oct 1, 2012Phase 2 study in Multiple MyelomaNCT01698801 · 26 enrolled · Japan
- Nov 7, 2012Phase 2 study in Leukemia-Lymphoma, Adult T-CellNCT01724177 · 26 enrolled · Japan
- Jun 28, 2013Phase 3 study in Newly Diagnosed, Previously Untreated Multiple MyelomaNCT01891643 · 23 enrolled · United States, Greece, Italy and more
- Sep 5, 2013Phase 3 study in Lymphoma, Non-HodgkinNCT01938001 · 358 enrolled · United States, Belgium, Brazil and more
- Nov 22, 2013Phase 3 study in Lymphoma, Non-HodgkinNCT01996865 · 503 enrolled · United States, Germany, Puerto Rico
- Apr 9, 2014Phase 3 study in Multiple MyelomaNCT02112175 · 46 enrolled · Belgium, France, Greece and more
- Jun 2, 2014Phase 3 study in Multiple MyelomaNCT02155634
- Nov 4, 2014Phase 3 study in Lymphoma, Large B-Cell, DiffuseNCT02285062 · 570 enrolled · United States, Australia, Belgium and more
- Jan 23, 2015Phase 2 study in Multiple MyelomaNCT02348528 · 65 enrolled · China
- Aug 11, 2015Phase 1 study in Healthy VolunteersNCT02521714 · 28 enrolled · United States
- Aug 25, 2015Phase 2 study in Leukemia, MyeloidNCT02538965 · 17 enrolled · United States, Canada
- Feb 16, 2016Phase 2 study in Multiple MyelomaNCT02685826 · 56 enrolled · United States, Canada, Denmark and more
- Aug 16, 2018Phase 3 study in Multiple MyelomaNCT03651128 · 386 enrolled · United States, Belgium, Canada and more
TargetBeta
“CRL4(CRBN) E3 ubiquitin ligase inhibitor; CRL4(CRBN) E3 ubiquitin ligase modulator”ChEMBL 37, by rule
Other programs on the same 4 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| pomalidomiderule | Bristol-Myers Squibb | phase 4 | 51 |
Studies
The newest 60 of 67 Bristol-Myers Squibb leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT03651128Multiple Myeloma · United States, Belgium, Canada and more | 3 | Completed | Apr 13, 2026 | 386 |
| NCT02685826Multiple Myeloma · United States, Canada, Denmark and more | 2 | Completed | Dec 15, 2017 | 56 |
| NCT02538965Leukemia, Myeloid · United States, Canada | 2 | Completed | Jul 22, 2017 | 17 |
| NCT02521714Healthy Volunteers · United States | 1 | Completed | Sep 23, 2015 | 28 |
| NCT02348528Multiple Myeloma · China | 2 | Completed | Sep 29, 2016 | 65 |
| NCT02285062Lymphoma, Large B-Cell, Diffuse · United States, Australia, Belgium and more | 3 | Completed | Mar 15, 2019 | 570 |
| NCT02155634Multiple Myeloma | 3 | Withdrawn | Apr 2017 | 0 |
| NCT02112175Multiple Myeloma · Belgium, France, Greece and more | 3 | Completed | Oct 12, 2020 | 46 |
| NCT01996865Lymphoma, Non-Hodgkin · United States, Germany, Puerto Rico | 3 | Completed | May 11, 2024 | 503 |
| NCT01938001Lymphoma, Non-Hodgkin · United States, Belgium, Brazil and more | 3 | Completed | Jun 22, 2018 | 358 |
| NCT01891643Newly Diagnosed, Previously Untreated Multiple Myeloma · United States, Greece, Italy and more | 3 | Terminated | Jun 25, 2020 | 23 |
| NCT01724177Leukemia-Lymphoma, Adult T-Cell · Japan | 2 | Completed | Nov 20, 2014 | 26 |
| NCT01698801Multiple Myeloma · Japan | 2 | Completed | Nov 26, 2013 | 26 |
| NCT01593410Multiple Myeloma · China | 2 | Completed | Jan 3, 2013 | 194 |
| NCT01476787Lymphoma, Follicular · United States, Japan | 3 | Completed | Apr 30, 2024 | 1,030 |
| NCT01358734Leukemia, Myeloid, Acute · United States, Canada | 2 | Completed | May 19, 2015 | 88 |
| NCT01197560Lymphoma, Large B-Cell, Diffuse · United States, Australia, Austria and more | 3 | Completed | Jul 4, 2013 | 111 |
| NCT01169298Leukemia-Lymphoma, Adult T-Cell · Japan | 1 | Completed | Dec 1, 2013 | 13 |
| NCT01032291Colorectal Neoplasms · Australia, Belgium, Germany and more | 2 | Terminated | Jan 2011 | 51 |
| NCT01029262Anemia · United States, Australia, Austria and more | 3 | Completed | Mar 17, 2013 | 239 |
| NCT01021423Lymphoma, Mantle-Cell · United States, Czechia, France and more | 3 | Terminated | Mar 1, 2011 | 9 |
| NCT00988208Prostatic Neoplasms · United States, Australia, Austria and more | 3 | Completed | Jan 13, 2012 | 1,059 |
| NCT00975806Carcinoma, Renal Cell · United States | 2 | Terminated | Oct 1, 2011 | 16 |
| NCT00963105Recurrence · United States, Canada, France and more | 2 | Completed | Sep 5, 2017 | 104 |
| NCT00928486Multiple Myeloma · Japan | 3 | Completed | Sep 10, 2010 | 25 |
| NCT00910910Leukemia, Lymphocytic, Chronic, B-Cell · United States, Australia, Austria and more | 3 | Completed | Mar 31, 2014 | 450 |
| NCT00910858Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) · United States | 2 | Completed | Apr 2006 | 40 |
| NCT00875667Lymphoma, Mantle-Cell · Belgium, Czechia, Denmark and more | 2 | Completed | Jun 28, 2018 | 254 |
| NCT00812968Myelodysplastic Syndromes · Japan | 2 | Completed | Sep 1, 2010 | 11 |
| NCT00774345Leukemia, Lymphocytic, Chronic, B-Cell · United States, Australia, Austria and more | 3 | Completed | Oct 27, 2020 | 317 |
| NCT00737529Lymphoma, Mantle-Cell · United States, Austria, Belgium and more | 2 | Completed | Apr 6, 2016 | 134 |
| NCT00689936Multiple Myeloma · United States, Australia, Austria and more | 3 | Completed | Jul 14, 2016 | 1,623 |
| NCT00655668Lymphoma, T-Cell · United States, Australia, Belgium and more | 2 | Terminated | Mar 1, 2010 | 54 |
| NCT00622336Multiple Myeloma · Russian Federation, Ukraine | 3 | Completed | Nov 25, 2013 | 330 |
| NCT00555100Multiple Myeloma · Japan | 1 | Completed | Dec 1, 2010 | 15 |
| NCT00478777Recurrence · Germany | 3 | Completed | Nov 2007 | 150 |
| NCT00474188Lymphoma, Large B-Cell, Diffuse · United States, Australia, Canada | 2 | Terminated | Dec 2008 | 26 |
| NCT00446433Crohn Disease · United States, France, Israel and more | 2 | Completed | 90 | |
| NCT00424047Multiple Myeloma · Australia, Austria, Belgium and more | 3 | Completed | Nov 1, 2005 | 351 |
| NCT00420849Multiple Myeloma · Australia, Austria, Ireland and more | 3 | Completed | Oct 2009 | 587 |
| NCT00419250Leukemia, Lymphocytic, Chronic, B-Cell · United States, Canada, Germany and more | 1 | Completed | Feb 1, 2010 | 52 |
| NCT00413036Lymphoma, Non-Hodgkin · United States, Canada, France and more | 2 | Completed | Apr 2011 | 217 |
| NCT00405756Newly Diagnosed Multiple Myeloma · Australia, Austria, Belarus and more | 3 | Completed | Nov 2009 | 459 |
| NCT00179660Lymphoma, Non-Hodgkin · United States | 2 | Completed | Jun 2008 | 50 |
| NCT00179647Multiple Myeloma · United States, Canada | 3 | Completed | Dec 2008 | 1,913 |
| NCT00179608Melanoma · United States | 1 | Completed | Jun 1, 2007 | 28 |
| NCT00179751Pancreatic Neoplasms · United States | 2 | Terminated | 50 | |
| NCT00179738Prostatic Neoplasms · United States | 2 | Terminated | 40 | |
| NCT00179725Ovarian Neoplasms · United States | 2 | Terminated | 60 | |
| NCT00179712Ovarian Neoplasms · United States | 2 | Completed | 60 | |
| NCT00179699Carcinoma, Non-Small-Cell Lung · United States | 1 | Terminated | 40 | |
| NCT00179686Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | 40 | |
| NCT00179673Lymphoma, Non-Hodgkin · United States, Canada | 2 | Completed | Apr 2008 | 43 |
| NCT00179621Myelodysplastic Syndromes · Belgium, France, Germany and more | 3 | Completed | Jun 2008 | 205 |
| NCT00120120Radiculopathy · United States | 3 | Completed | Oct 2007 | 181 |
| NCT00109772Reflex Sympathetic Dystrophy · United States | 2 | Terminated | Apr 2008 | 184 |
| NCT00091624Multiple Myeloma · United States | 1 | Completed | Sep 2007 | 77 |
| NCT00067743Complex Regional Pain Syndromes · United States | 2 | Completed | Oct 2004 | 40 |
| NCT00065351Multiple Myeloma · United States | 2 | Completed | Oct 1, 2006 | 222 |
| NCT00065156Myelodysplastic Syndromes · United States, Germany | 2 | Completed | Aug 1, 2008 | 148 |
How it is read
Names in the registry
- “Lenalidomide”, 67 entries
- “lenalidomide”, 16 entries
- “CC-5013”, 14 entries
- “Drug: Carfilzomib + Lenalidomide + Dexamethasone”, 1 entry
- “Tafasitamab plus lenalidomide”, 1 entry
Conditions, from the studies’ own filings
- Multiple Myeloma, 45 studies
- Lymphoma, Large B-Cell, Diffuse, 10 studies
- Myelodysplastic Syndromes, 8 studies
- Lymphoma, Non-Hodgkin, 5 studies
- Lymphoma, Mantle-Cell, 5 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.